PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CIR vs. OLMA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


CIROLMA

Fundamentals


CIROLMA
Market Cap$1.14B$596.81M
EPS$1.44-$2.14
Revenue (TTM)$821.79M$0.00
Gross Profit (TTM)$259.84M$0.00
EBITDA (TTM)$130.30M-$104.58M

Correlation

-0.50.00.51.00.2

The correlation between CIR and OLMA is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

CIR vs. OLMA - Performance Comparison

The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%20.00%40.00%60.00%December2024FebruaryMarchAprilMay
53.97%
-78.22%
CIR
OLMA

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CIRCOR International, Inc.

Olema Pharmaceuticals, Inc.

Risk-Adjusted Performance

CIR vs. OLMA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for CIRCOR International, Inc. (CIR) and Olema Pharmaceuticals, Inc. (OLMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CIR
Sharpe ratio
The chart of Sharpe ratio for CIR, currently valued at 1.97, compared to the broader market-2.00-1.000.001.002.003.004.001.97
Sortino ratio
The chart of Sortino ratio for CIR, currently valued at 9.82, compared to the broader market-4.00-2.000.002.004.006.009.82
Omega ratio
The chart of Omega ratio for CIR, currently valued at 3.97, compared to the broader market0.501.001.503.97
Calmar ratio
The chart of Calmar ratio for CIR, currently valued at 2.88, compared to the broader market0.002.004.006.002.88
Martin ratio
The chart of Martin ratio for CIR, currently valued at 77.48, compared to the broader market-10.000.0010.0020.0030.0077.48
OLMA
Sharpe ratio
The chart of Sharpe ratio for OLMA, currently valued at 0.91, compared to the broader market-2.00-1.000.001.002.003.004.000.91
Sortino ratio
The chart of Sortino ratio for OLMA, currently valued at 1.72, compared to the broader market-4.00-2.000.002.004.006.001.72
Omega ratio
The chart of Omega ratio for OLMA, currently valued at 1.20, compared to the broader market0.501.001.501.20
Calmar ratio
The chart of Calmar ratio for OLMA, currently valued at 0.87, compared to the broader market0.002.004.006.000.87
Martin ratio
The chart of Martin ratio for OLMA, currently valued at 3.77, compared to the broader market-10.000.0010.0020.0030.003.77

CIR vs. OLMA - Sharpe Ratio Comparison


Rolling 12-month Sharpe Ratio1.002.003.004.005.006.00December2024FebruaryMarchAprilMay
1.97
0.91
CIR
OLMA

Dividends

CIR vs. OLMA - Dividend Comparison

Neither CIR nor OLMA has paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
CIR
CIRCOR International, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.31%0.23%0.36%0.25%0.19%
OLMA
Olema Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

CIR vs. OLMA - Drawdown Comparison


-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-0.80%
-80.42%
CIR
OLMA

Volatility

CIR vs. OLMA - Volatility Comparison

The current volatility for CIRCOR International, Inc. (CIR) is 0.00%, while Olema Pharmaceuticals, Inc. (OLMA) has a volatility of 16.60%. This indicates that CIR experiences smaller price fluctuations and is considered to be less risky than OLMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%December2024FebruaryMarchAprilMay0
16.60%
CIR
OLMA

Financials

CIR vs. OLMA - Financials Comparison

This section allows you to compare key financial metrics between CIRCOR International, Inc. and Olema Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items